CS268191B2 - Method of new 4,5-dihydrooxazole derivatives production - Google Patents

Method of new 4,5-dihydrooxazole derivatives production Download PDF

Info

Publication number
CS268191B2
CS268191B2 CS876497A CS649787A CS268191B2 CS 268191 B2 CS268191 B2 CS 268191B2 CS 876497 A CS876497 A CS 876497A CS 649787 A CS649787 A CS 649787A CS 268191 B2 CS268191 B2 CS 268191B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
mmol
hydrogen
oxazolyl
Prior art date
Application number
CS876497A
Other languages
Czech (cs)
English (en)
Other versions
CS649787A2 (en
Inventor
Dieter Dr Binder
Franz Dipl Ing Rovenszky
Hubert Peter Dr Ferber
Original Assignee
Chemie Linz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemie Linz Ag filed Critical Chemie Linz Ag
Publication of CS649787A2 publication Critical patent/CS649787A2/cs
Publication of CS268191B2 publication Critical patent/CS268191B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
CS876497A 1986-09-10 1987-09-08 Method of new 4,5-dihydrooxazole derivatives production CS268191B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT243786 1986-09-10

Publications (2)

Publication Number Publication Date
CS649787A2 CS649787A2 (en) 1989-05-12
CS268191B2 true CS268191B2 (en) 1990-03-14

Family

ID=3534337

Family Applications (1)

Application Number Title Priority Date Filing Date
CS876497A CS268191B2 (en) 1986-09-10 1987-09-08 Method of new 4,5-dihydrooxazole derivatives production

Country Status (21)

Country Link
US (1) US4818760A (no)
EP (1) EP0261478B1 (no)
JP (1) JPS6377878A (no)
KR (1) KR880003941A (no)
AT (1) ATE62908T1 (no)
AU (1) AU596869B2 (no)
CA (1) CA1256109A (no)
CS (1) CS268191B2 (no)
DD (1) DD262230A5 (no)
DE (1) DE3769563D1 (no)
DK (1) DK165322C (no)
ES (1) ES2028838T3 (no)
FI (1) FI89267C (no)
GR (1) GR3001842T3 (no)
HU (1) HU198059B (no)
MY (1) MY102003A (no)
NO (1) NO165195C (no)
NZ (1) NZ221723A (no)
SG (1) SG39892G (no)
SU (1) SU1574177A3 (no)
ZA (1) ZA876740B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0983263A1 (en) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
PT1187601E (pt) 1999-06-07 2005-11-30 Altana Pharma Ag Nova forma de preparacao e a administracao compreendendo um inibidor da bomba de protoes instavel em meio acido
WO2004012659A2 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
ES2376466T3 (es) * 2004-05-07 2012-03-14 Nycomed Gmbh Forma de dosificación farmacéutica que comprende peletes, as�? como su procedimiento de fabricación.
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CA2648280C (en) * 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB8305245D0 (en) * 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
FI861772A (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
ES2032394T3 (es) * 1986-02-20 1993-02-16 Hoechst Aktiengesellschaft Procedimiento para preparar derivados de tienoimidazol sustituidos.

Also Published As

Publication number Publication date
AU7817087A (en) 1988-03-17
NO165195C (no) 1991-01-09
GR3001842T3 (en) 1992-11-23
SU1574177A3 (ru) 1990-06-23
MY102003A (en) 1992-02-29
DK165322C (da) 1993-03-29
EP0261478B1 (de) 1991-04-24
CA1256109A (en) 1989-06-20
HU198059B (en) 1989-07-28
JPS6377878A (ja) 1988-04-08
FI873892A0 (fi) 1987-09-09
FI89267B (fi) 1993-05-31
EP0261478A1 (de) 1988-03-30
FI89267C (fi) 1993-09-10
NO165195B (no) 1990-10-01
ZA876740B (en) 1988-03-14
KR880003941A (ko) 1988-05-31
CS649787A2 (en) 1989-05-12
SG39892G (en) 1992-10-02
DE3769563D1 (de) 1991-05-29
HUT47288A (en) 1989-02-28
NO873722L (no) 1988-03-11
US4818760A (en) 1989-04-04
NZ221723A (en) 1989-11-28
DK165322B (da) 1992-11-09
NO873722D0 (no) 1987-09-07
ATE62908T1 (de) 1991-05-15
DK469687D0 (da) 1987-09-09
AU596869B2 (en) 1990-05-17
FI873892A (fi) 1988-03-11
DD262230A5 (de) 1988-11-23
DK469687A (da) 1988-03-11
ES2028838T3 (es) 1992-07-16

Similar Documents

Publication Publication Date Title
US4472409A (en) 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
US4248880A (en) Treatment of gastric ulcers with naphthimidazole derivatives
DK150510B (da) Analogifremgangsmaade til fremstilling af substituerede 2-(2-benzimidazolyl)-pyridiner eller terapeutisk acceptable salte deraf
CH665417A5 (fr) Derives du benzimidazole, procede pour leur preparation et agents anti-ulceres contenant ces derives.
NZ208023A (en) Heterocyclic fluoroalkoxy compounds and pharmaceutical compositions
CS268191B2 (en) Method of new 4,5-dihydrooxazole derivatives production
EP0283504A1 (en) Compounds
JPH03388B2 (no)
NO861802L (no) Nye derivater av tieno(2,3-d)imidazoler og fremgangsmaate til deres fremstilling.
KR900004828B1 (ko) 페닐-나프티리딘의 제조방법
US5037830A (en) Novel thiouracyl derivatives, pharmaceutical compositions containing them and process for preparing same
EP0354788A1 (en) Novel imidazole derivatives
FR2576900A1 (fr) Derives de cyclohepto-imidazole 2-substitue, agents anti-ulcereux et procede pour leur preparation
JP2794640B2 (ja) イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JP2816974B2 (ja) ベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
EP0452076B1 (en) Thiazole and imidazole derivatives and antiulcer composition containing same
CS264298B2 (cs) Způsob výroby dusíkatých arylmethoxythiofenových derivátů
JPS61221175A (ja) ベンズイミダゾ−ル誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
KR810000633B1 (ko) 이미다졸 유도체의 제조방법
FR2640975A1 (no)
JPH0430953B2 (no)
JPH03223260A (ja) ベンズイミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JPH037279A (ja) ２―チオピランカルボチオアミド誘導体
LU83322A1 (fr) 6-(pyridinyl)-3(2h)-pyridazinones 4-substitutees,leur preparation,leur utilisation comme agents cardiotoniques,et composes intermediaires.
JPH046713B2 (no)